DavidCGeierMD

PubMed

• Systematic Assessment of Research on Autism Spectrum Disorder and Mercury Reveals Conflicts of Interest and the Need for Transparency in Autism Research.
  Kern, J. K.,Geier, D. A.,Deth, R. C.,Sykes, L. K.,Hooker, B. S.,Love, J. M.,Bjørklund, G.,Chaigneau, C. G.,Haley, B. E.,Geier, M. R.> ;Sci Eng Ethics. 2015 Oct 29
• Thimerosal: Clinical, epidemiologic and biochemical studies.
  Geier, D. A.,King, P. G.,Hooker, B. S.,Dórea, J. G.,Kern, J. K.,Sykes, L. K.,Geier, M. R.> ;Clin. Chim. Acta. 2015 Feb 25
• Shared Brain Connectivity Issues, Symptoms, and Comorbidities in Autism Spectrum Disorder, Attention Deficit/Hyperactivity Disorder, and Tourette Syndrome.
  Kern, J. K.,Geier, D.,King, P.,Sykes, L.,Mehta, J.,Geier, M.> ;Brain Connect. 2015 Jan 21
• A Case-Control Study Evaluating the Relationship Between Thimerosal-Containing Haemophilus influenzae Type b Vaccine Administration and the Risk for a Pervasive Develo...
  Geier, D. A.,Kern, J. K.,King, P. G.,Sykes, L. K.,Geier, M. R.> ;Biol Trace Elem Res. 2014 Nov 11
• Thimerosal-containing hepatitis B vaccination and the risk for diagnosed specific delays in development in the United States: a case-control study in the vaccine safet...
  Geier, D. A.,Kern, J. K.,Hooker, B. S.,King, P. G.,Sykes, L. K.,Geier, M. R.> ;N Am J Med Sci. 2014 Dec 10
• An Evaluation of the Effect of Increasing Parental Age on the Phenotypic Severity of Autism Spectrum Disorder.
  Geier, D. A.,Hooker, B. S.,Kern, J. K.,Sykes, L. K.,Geier, M. R.> ;J. Child Neurol.. 2014 Aug 29
• New science challenges old notion that mercury dental amalgam is safe.
  Homme, K. G.,Kern, J. K.,Haley, B. E.,Geier, D. A.,King, P. G.,Sykes, L. K.,Geier, M. R.> ;Biometals. 2014 Jan 15
• Evaluation of regression in autism spectrum disorder based on parental reports.
  Kern, J. K.,Geier, D. A.,Geier, M. R.> ;N Am J Med Sci. 2014 Mar 29
• A Comparison of the Autism Treatment Evaluation Checklist (ATEC) and the Childhood Autism Rating Scale (CARS) for the Quantitative Evaluation of Autism.
  Geier, D. A.,Kern, J. K.,Geier, M. R.> ;J Ment Health Res Intellect Disabil. 2013 Oct
• L-Carnitine Exposure and Mitochondrial Function in Human Neuronal Cells.
  Geier, D. A.,Geier, M. R.> ;Neurochem. Res.. 2013 Nov
• Handgrip strength in autism spectrum disorder compared with controls.
  Kern, J. K.,Geier, D. A.,Adams, J. B.,Troutman, M. R.,Davis, G. A.,King, P. G.,Geier, M. R.> ;J Strength Cond Res. 2013 Aug
• A prospective Cross-sectional Cohort Assessment of Health, Physical, and Behavioral Problems in Autism Spectrum Disorders.
  Geier, D. A.,Kern, J. K.,Geier, M. R.> ;Maedica (Buchar). 2012 Sep
• The temporal relationship between RotaTeq immunization and intussusception adverse events in the Vaccine Adverse Event Reporting System (VAERS).
  Geier, D. A., King, P. G., Sykes, L. K., Geier, M. R.> ;Med Sci Monit. 2012 Feb
• A dose-dependent relationship between mercury exposure from dental amalgams and urinary mercury levels: a further assessment of the Casa Pia Children's Dental Amalgam ...
  Geier, D. A., Carmody, T., Kern, J. K., King, P. G., Geier, M. R.> ;Hum Exp Toxicol. 2012 Jan
• A clinical trial of glutathione supplementation in autism spectrum disorders.
  Kern, J. K., Geier, D. A., Adams, J. B., Garver, C. R., Audhya, T., Geier, M. R.> ;Med Sci Monit. 2011 Dec
• A prospective double-blind, randomized clinical trial of levocarnitine to treat autism spectrum disorders.
  Geier, D. A., Kern, J. K., Davis, G., King, P. G., Adams, J. B., Young, J. L., Geier, M. R.> ;Med Sci Monit. 2011 Jun
• A significant relationship between mercury exposure from dental amalgams and urinary porphyrins: a further assessment of the Casa Pia children''s dental amalgam trial.
  Geier, D. A., Carmody, T., Kern, J. K., King, P. G., Geier, M. R.> ;Biometals. 2011 Apr
• Toxicity biomarkers in autism spectrum disorder: a blinded study of urinary porphyrins.
  Kern, J. K., Geier, D. A., Adams, J. B., Mehta, J. A., Grannemann, B. D., Geier, M. R.> ;Pediatr Int. 2011 Apr
• A biomarker of mercury body-burden correlated with diagnostic domain specific clinical symptoms of autism spectrum disorder.
  Kern, J. K., Geier, D. A., Adams, J. B., Geier, M. R.> ;Biometals. 2010 Dec
• The biological basis of autism spectrum disorders: Understanding causation and treatment by clinical geneticists.
  Geier, D. A., Kern, J. K., Geier, M. R.> ;Acta Neurobiol Exp (Wars). 2010
• Blood mercury levels in autism spectrum disorder: Is there a threshold level?
  Geier, D. A., Audhya, T., Kern, J. K., Geier, M. R.> ;Acta Neurobiol Exp (Wars). 2010
• The relative toxicity of compounds used as preservatives in vaccines and biologics.
  Geier, D. A., Jordan, S. K., Geier, M. R.> ;Med Sci Monit. 2010 May
• Thimerosal exposure & increasing trends of premature puberty in the vaccine safety datalink.
  Geier, D. A., Young, H. A., Geier, M. R.> ;Indian J Med Res. 2010 Apr
• A prospective blinded evaluation of urinary porphyrins verses the clinical severity of autism spectrum disorders.
  Geier, D. A., Kern, J. K., Geier, M. R.> ;J Toxicol Environ Health Part A. 2009
• A prospective study of prenatal mercury exposure from maternal dental amalgams and autism severity.
  Geier, D. A., Kern, J. K., Geier, M. R.> ;Acta Neurobiol Exp (Wars). 2009 Jul 14
• Join now to see all